Overview of Epstein-Barr virus-associated diseases in Japan

Critical Reviews in Oncology/Hematology

Volumn 44, Issue 3, 2002, Pages 193-202

  Wakiguchi, Hiroshi ^a  

^a KOCHI MEDICAL SCHOOL   (Japan)

Author keywords

ALPS; EBV associated diseases; Gastric cancer; GLPD; HCC; Mosquito allergy; PTLD; SCAEBV; VAHS

Indexed keywords

FAS LIGAND;

AUTOIMMUNE DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; B LYMPHOCYTE; CELL DEATH; CONFERENCE PAPER; DISEASE SEVERITY; EPITHELIUM CELL; EPSTEIN BARR VIRUS; HEMOPHAGOCYTIC HISTIOCYTOSIS; HISTIOCYTOSIS; HUMAN; HYPERSENSITIVITY; IMMUNE DEFICIENCY; INFANT; INFECTIOUS MONONUCLEOSIS; INSECT BITE; JAPAN; LARGE GRANULAR LYMPHOCYTE; LIVER CELL CARCINOMA; LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; MALIGNANT NEOPLASTIC DISEASE; MOSQUITO; NATURAL KILLER CELL; PLEURA EMPYEMA; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISORDER; STOMACH CARCINOMA; T LYMPHOCYTE; VIRUS INFECTION; ACUTE DISEASE; CHRONIC DISEASE; REVIEW;

ACUTE DISEASE; CHRONIC DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; HUMANS; JAPAN;

EID: 0036899638     PISSN: 10408428     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1040-8428(02)00111-7     Document Type: Conference Paper

References (73)

1. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-type virus to infectious mononucleosis. Proc. Natl. Acad. Sci. USA. 59:1968;94-101.
2. Sumaya C.V., Ench Y. Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics. 75:1985;1011-1019.
3. Hanto D.W. Classification of Epstein-Barr virus-associated posttransplant lymphoproliferative diseases: implications for understanding their pathogenesis and developing rational treatment strategies. Annu. Rev. Med. 46:1995;381-394.
4. Hanto D.W., Sakamoto K., Purtilo D.T., Simmons R.L., Najarian J.S. The Epstein-Barr virus in the pathogenesis of posttransplant lymphoproliferative disorders. Clinical, pathologic, and virologic correlation. Surgery. 90:1981;204-213.
5. Geser A., Lenoir G.M., Anvret M., Bornkamm G., Klein G., Williams E.H., Wright D.H., De-The G. Epstein-Barr virus markers in a series of Burkitt's lymphomas from the West Nile District, Uganda. Eur. J. Cancer Clin. Oncol. 19:1983;1393-1404.
6. Nonoyama M., Pagano J.S. Homology between Epstein-Barr virus DNA and viral DNA from Burkitt's lymphoma and nasopharyngeal carcinoma determined by DNA-DNA reassociation kinetics. Nature. 242:1973;44-47.
7. Ingbar M.L., Whitney B.J., Taylor L.D. Differences in the costs of nursing service: a statistical study of community hospitals in Massachusetts. Am. J. Public Health Nations Health. 56:1966;1699-1715.
8. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 228:1970;1056-1058.
9. Weiss L.M., Movahed L.A., Warnke R.A., Sklar J. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. New Engl. J. Med. 320:1989;502-506.
10. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Muller-Lantzsch N., Stein H. Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells. Proc. Natl. Acad. Sci. USA. 88:1991;4766-4770.
11. Shibata D., Tokunaga M., Uemura Y., Sato E., Tanaka S., Weiss L.M. Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am. J. Pathol. 139:1991;469-474.
12. Imai S., Koizumi S., Sugiura M., Tokunaga M., Uemura Y., Yamamoto N., Tanaka S., Sato E., Osato T. Gastric carcinoma: monoclonal epithelial malignant cells expressing Epstein-Barr virus latent infection protein. Proc. Natl. Acad. Sci. USA. 91:1994;9131-9135.
13. Ishihara S., Okada S., Wakiguchi H., Kurashige T., Morishima T., Kawa-Ha K. Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatr. 84:1995;1271-1275.
14. Straus S.E. The chronic mononucleosis syndrome. J. Infect. Dis. 157:1988;405-412.
15. Maeda A., Wakiguchi H., Yokoyama W., Hisakawa H., Tomoda T., Kurashige T. Persistently high Epstein-Barr virus (EBV) loads in peripheral blood lymphocytes from patients with chronic active EBV infection. J. Infect. Dis. 179:1999;1012-1015.
16. Wilson E.R., Malluh A., Stagno S., Crist W.M. Fatal Epstein-Barr virus-associated hemophagocytic syndrome. J. Pediatr. 98:1981;260-262.
17. Sullivan J.L., Woda B.A., Herrod H.G., Koh G., Rivara F.P., Mulder C. Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood. 65:1985;1097-1104.
18. Ishihara S., Ohshima K., Tokura Y., Yabuta R., Imaishi H., Wakiguchi H., Kurashige T., Kishimoto H., Katayama I., Okada S., Kawa-Ha K. Hypersensitivity to mosquito bites conceals clonal lymphoproliferation of Epstein-Barr viral DNA-positive natural killer cells. Jpn. J. Cancer Res. 88:1997;82-87.
19. Kawa-Ha K., Ishihara S., Ninomiya T., Yumura-Yagi K., Hara J., Murayama F., Tawa A., Hirai K. CD3-negative lymphoproliferative disease of granular lymphocytes containing Epstein-Barr viral DNA. J. Clin. Invest. 84:1989;51-55.
20. Purtilo D.T., Cassel C.K., Yang J.P., Harper R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet. 1:1975;935-940.
21. Sullivan J.L., Byron K.S., Brewster F.E., Baker S.M., Ochs H.D. X-linked lymphoproliferative syndrome. Natural history of the immunodeficiency. J. Clin. Invest. 71:1983;1765-1778.
22. Coffey A.J., Brooksbank R.A., Brandau O., Oohashi T., Howell G.R., Bye J.M., Cahn A.P., Durham J., Heath P., Wray P., Pavitt R., Wilkinson J., Leversha M., Huckle E., Shaw-Smith C.J., Dunham A., Rhodes S., Schuster V., Porta G., Yin L., Serafini P., Sylla B., Zollo M., Franco B., Bentley D.R., et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nat. Genet. 20:1998;129-135.
23. Sayos J., Wu C., Morra M., Wang N., Zhang X., Allen D., van Schaik S., Notarangelo L., Geha R., Roncarolo M.G., Oettgen H., De Vries J.E., Aversa G., Terhorst C. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature. 395:1998;462-469.
24. Iuchi K., Aozasa K., Yamamoto S., Mori T., Tajima K., Minato K., Mukai K., Komatsu H., Tagaki T., Kobashi Y. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn. J. Clin. Oncol. 19:1989;249-257.
25. Sugawara Y., Mizugaki Y., Uchida T., Torii T., Imai S., Makuuchi M., Takada K. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology. 256:1999;196-202.
26. Dianzani U., Bragardo M., DiFranco D., Alliaudi C., Scagni P., Buonfiglio D., Redoglia V., Bonissoni S., Correra A., Dianzani I., Ramenghi U. Deficiency of the Fas apoptosis pathway without Fas gene mutations in pediatric patients with autoimmunity/lymphoproliferation. Blood. 89:1997;2871-2879.
27. Wang J., Zheng L., Lobito A., Chan F.K., Dale J., Sneller M., Yao X., Puck J.M., Straus S.E., Lenardo M.J. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. Cell. 98:1999;47-58.
28. Wakiguchi H., Fujieda M., Matsumoto K., Ohara Y., Wakiguchi A., Kurashige T., Kitamura I., Yamauchi T., Hatano Y. Clinicoimmunological studies on infantile Epstein-Barr (EB) virus infection. 2. Comparison of anti-EB-virus antibody titer among patients of various age. Clin. Virol. 15:1987;247-253.
29. Wakiguchi H., Fujieda M., Matsumoto K., Ohara Y., Wakiguchi A., Shiraishi T., Kurashige T., Kitamura I. Clinicoimmunological studies on infantile Epstein-Barr virus infection. 1. Comparison of liver function tests among various age of the patients. Shounika Rinshou. 40:1987;3001-3005.
30. Wakiguchi H., Wakiguchi A., Fujieda M., Matsumoto K., Ohara Y., Shiraishi T., Kurashige T., Kitamura I. Studies on cellular immunity to Epstein-Barr virus. III. Comparison of Epstein-Barr virus specific cytotoxic T-lymphocytes and EBNA antibodies. J. Jpn. Pediatr. Assoc. 90:1986;2466-2472.
31. Wakiguchi H., Fujieda M., Matsumoto K., Zushi N., Ohara Y., Tone Y., Wakiguchi A., Kurashige T. Clinical and immunological studies on acute Epstein-Barr (EB) virus infection in infants and children. 3. EB-virus specific cytotoxic T-lymphocyte activity and leukocytes response compared by age and clinical disease. J. Jpn. Pediatr. Assoc. 91:1987;2843-2848.
32. Wakiguchi H., Hisakawa H., Kubota H., Kurashige T. Strong response of T-cells in infants with dual infection by Epstein-Barr virus and cytomegalovirus. Pediatr. Int. 41:1999;484-489.
33. Hamblin T.J., Hussain J., Akbar A.N., Tang Y.C., Smith J.L., Jones D.B. Immunological reason for chronic ill health after infectious mononucleosis. Br. Med. J. 287:1983;85-88.
34. Holmes G.P., Kaplan J.E., Stewart J.A., Hunt B., Pinsky P.F., Schonberger L.B. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr virus the cause. J. Am. Med. Assoc. 257:1987;2297-2302.
35. Wakiguchi H., Fujieda M., Matsumoto K., Ohara Y., Wakiguchi A., Kurashige T. Defective killer cell activity in patients with chronic active Epstein-Barr virus infection. Acta Med. Okayama. 42:1988;137-142.
36. Kikuta H., Taguchi Y., Tomizawa K., Kojima K., Kawamura N., Ishizaka A., Sakiyama Y., Matsumoto S., Imai S., Kinoshita T., Kinoshita T., Koizumi S., Osato T., Kobayashi I., Hamada I., Hirai K. Epstein-Barr virus genome-positive T-lymphocytes in a boy with chronic active EBV infection associated with Kawasaki-like disease. Nature. 333:1988;455-457.
37. Satoh T., Kojima M., Ohshima K. Demonstration of the Epstein-Barr genome by the polymerase chain reaction and in situ hybridization in a patient with viral pericarditis. Br. Heart J. 69:1993;563-564.
38. Kimura H., Hoshino Y., Kanegane H., Tsuge I., Okamura T., Kawa K., Morishima T. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 98:2001;280-286.
39. Okano M., Matsumoto S., Osato T., Sakiyama Y., Thiele G.M., Purtilo D.T. Severe chronic active Epstein-Barr virus infection syndrome. Clin. Microbiol. Rev. 4:1991;129-135.
40. Kobayashi I., Hamada I., Tomizawa K., Kikuta H., Sakiyama Y., Matsumoto S. Chronic Epstein-Barr virus infections associated with coronary aneurysms. Acta Paediatr. Jpn. 31:1989;509-512.
41. Fujieda M., Wakiguchi H., Hisakawa H., Kubota H., Kurashige T. Defective activity of Epstein-Barr virus (EBV) specific cytotoxic T-lymphocytes in children with chronic active EBV infection and in their parents. Acta Paediatr. Jpn. 35:1993;394-399.
42. Wakiguchi H., Hisakawa H., Kubota H., Kurashige T. Serodiagnosis of infectious mononucleosis in children. Acta Paediatr. Jpn. 40:1998;328-332.
43. Yanagisawa M. Analysis of killer cell activities in Epstein-Barr virus infections. Acta Paediatr. Jpn. 29:1987;815-823.
44. Ishihara S., Tawa A., Yumura-Yagi K., Murata M., Hara J., Yabuuchi H., Hirai K., Kawa-Ha K. Clonal T-cell lymphoproliferation containing Epstein-Barr (EB) virus DNA in a patient with chronic active EB-virus infection. Am. J. Hematol. 54:1997;276-281.
45. Kikuta H., Nakanishi M., Sakiyama Y., matsumoto S. Chronic active Epstein-Barr virus (EBV) infection is associated with clonotypic intracellular terminal regions of the EBV. J. Infect. Dis. 160:1989;546-547.
46. Noma T., Kou K., Yoshizawa I., Kawano Y., Miyashita T., Mizutani T., Yata J. monoclonal proliferation of Epstein-Barr virus-infected T-cells in a patient with virus-associated haemophagocytic syndrome. Eur. J. Pediatr. 153:1994;734-738.
47. Kanegane H., Wakiguchi H., Kanegane C., Kurashige T., Miyawaki T., Tosato G. Increased cell-free viral DNA in fatal cases of chronic active Epstein-Barr virus infection. Clin. Infect. Dis. 28:1999;906-909.
48. Kanegane H., Wakiguchi H., Kanegane C., Kurashige T., Tosato G. Viral interleukin-10 in chronic active Epstein-Barr virus infection. J. Infect. Dis. 176:1997;254-257.
49. Yamauchi Y., Tachibana Y., Maeda A., Wakiguchi H., Usui M., Kurata T., Sairenji T. Evaluation of antibodies to the Epstein-Barr virus immediate early gene product ZEBRA by a new enzyme-linked immunosorbent assay. Intervirology. 41:1998;278-284.
50. Risdall R.J., McKenna R.W., Nesbit M.E., Krivit W., Balfour H.H. Jr, Simmons R.L., Brunning R.D. Virus-associated hemophagocytic syndrome: a benign histiocytic proliferation distinct from malignant histiocytosis. Cancer. 44:1979;993-1002.
51. Kawaguchi H., Miyashita T., Herbst H., Niedobitek G., Asada M., Tsuchida M., Hanada R., Kinoshita A., Sakurai M., Kobayashi N. Epstein-Barr virus-infected T-lymphocytes in Epstein-Barr virus-associated hemophagocytic syndrome. J. Clin. Invest. 92:1993;1444-1450.
52. Imashuku S., Hibi S., Fujiwara F., Ikushima S., Todo S. Haemophagocytic lymphohistiocytosis, interferon-γ-naemia and Epstein-Barr virus involvement. Br. J. Haematol. 88:1994;656-658.
53. Imashuku S., Hibi S., Sako M., Ishida Y., Mugishima H., Chen J., Tsunematsu Y. Soluble interleukin-2 receptor: a useful prognostic factor for patients with hemophagocytic lymphohistiocytosis. Blood. 86:1995;4706-4707.
54. Straus S.E., Sneller M., Lenardo M.J., Puck J.M., Strober W. An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann. Intern. Med. 130:1999;591-601.
55. Kanegane H., Wakiguchi H. Interleukin 10 in EB-virus infection. Infect. Immun. Child. 11:1999;151-156.
56. Kasahara Y., Wada T., Nilda Y., Yachie A., Seki H., Ishida Y., Sakai T., Koizumi F., Koizumi S., Miyawaki T., Taniguchi N. Novel Fas (CD95/Apo-1) mutation in infants with a lymphoproliferative disorder. Int. Immunol. 10:1998;195-202.
57. Nichols K.E., Harkin D.P., Levitz S., Krainer M., Kolquist K.A., Genovese C., Bernard A., Ferguson M., Zuo L., Snyder E., Buckler A.J., Wise C., Ashley J., Lovett M., Valentine M.B., Look A.T., Gerald W., Housman D.E., Haber D.A. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl. Acad. Sci. USA. 95:1998;13765-13770.
58. Sumazaki R., Kanegane H., Osaki M., Fukushima T., Tsuchida M., Matsukura H., Shinozaki K., Kimura H., Matsui A., Miyawaki T. SH2D1A mutations in Japanese males with severe Epstein-Barr virus - associated illnesses. Blood. 98:2001;1268-1270.
59. Sumegi J., Huang D., Lanyi A., Davis J.D., Seemayer T.A., Maeda A., Klein G., Seri M., Wakiguchi H., Purtilo D.T., Gross T.G. Correlation of mutations of the SH2D1A gene and Epstein-Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood. 96:2000;3118-3125.
60. Nakanishi M., Kikuta H., Tomizawa K., Kojima K., Ishizaka A., Okano M., Sakiyama Y., Matsumoto S. Distinct clonotypic Epstein-Barr virus-induced fatal lymphoproliferative disorder in a patient with Wiskott-Aldrich syndrome. Cancer. 72:1993;1376-1381.
61. Hoshino Y., Kimura H., Kuzushima K., Tsurumi T., Nemoto K., Kikuta A., Nishiyama Y., Kojima S., Matsuyama T., Morishima T. Early intervention in post-transplant lymphoproliferative disorders based on Epstein-Barr viral load. Bone Marrow Transplant. 26:2000;199-201.
62. Orii T., Ohkohchi N., Kikuchi H., Koyamada N., Chubachi S., Satomi S., Kimura H., Hoshino Y., Morita M. Usefulness of quantitative real-time polymerase chain reaction in following up patients with Epstein-Barr virus infection after liver transplantation. Clin. Transplant. 14:2000;308-317.
63. Kuzushima K., Kimura H., Hoshino Y., Yoshimi A., Tsuge I., Horibe K., Morishima T., Tsurumi T., Kojima S. Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder. J. Infect. Dis. 182:2000;937-940.
64. Harabuchi Y., Yamanaka N., Kataura A., Imai S., Kinoshita T., Mizuno F., Osato T. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet. 335:1990;128-130.
65. + immunophenotype and polymorphic-reticulosis morphology. Int. J. Cancer. 70:1997;9-13.
66. Iuchi K., Ichimiya A., Akashi A., Mizuta T., Lee Y.E., Tada H., Mori T., Sawamura K., Lee Y.S., Furuse K. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Cancer. 60:1987;1771-1775.
67. Fukayama M., Ibuka T., Hayashi Y., Ooba T., Koike M., Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am. J. Pathol. 143:1993;1044-1049.
68. Hongyo T., Kurooka M., Taniguchi E., Iuchi K., Nakajima Y., Aozasa K., Nomura T. Frequent p53 mutations at dipyrimidine sites in patients with pyothorax-associated lymphoma. Cancer Res. 58:1998;1105-1107.
69. Kanno H., Ohsawa M., Hashimoto M., Iuchi K., Nakajima Y., Aozasa K. HLA-A allels of patients with pyothorax-associated lymphoma: anti-Epstein-Barr virus (EBV) host immune responses during the development of EBV latent antigen-positive lymphomas. Int. J. Cancer. 82:1999;630-634.
70. Sugiura M., Imai S., Tokunaga M., Koizumi S., Uchizawa M., Okamoto K., Osato T. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells. Br. J. Cancer. 74:1996;625-631.
71. Nishikawa J., Imai S., Oda T., Kojima T., Okita K., Takada K. Epstein-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J. Virol. 73:1999;1286-1292.
72. Tajima M., Komuro M., Okinaga K. Establishment of Epstein-Barr virus-positive human gastric epithelial cell lines. Jpn. J. Cancer Res. 89:1998;262-268.
73. Sugawara Y., Mizugaki Y., Uchida T., Torii T., Imai S., Makuuchi M., Takada K. Detection of Epstein-Barr virus (EBV) in hepatocellular carcinoma tissue: a novel EBV latency characterized by the absence of EBV-encoded small RNA expression. Virology. 256:1999;196-202.